ATOS · Atossa Therapeutics Inc
United States · RS rating 26 · As of 2026-11-03
| Price | 2.33 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 45 / 61 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 13 / 21 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +14.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +82.7% |
| Market cap (USD) | $49.3M |